About the company
The Cooper Companies is an esteemed eye care company that has solidified its position as one of the largest in the United States. Recognized for its commitment to delivering innovative solutions, Cooper operates through two key segments: CooperVision and CooperSurgical. These divisions cater to different aspects of eye care, offering a diverse range of products and services. CooperVision, the company's pure-play contact lens business, is truly impressive. With a comprehensive suite of products, it addresses the needs of individuals requiring spherical, multifocal, and toric contact lenses. The brand boasts an extensive portfolio, including popular names like Proclear, Biofinity, MyDay, and clariti. With such variety, CooperVision has gained an enviable market share, controlling approximately a quarter of the U.S. contact lens market. However, CooperVision's offerings do not end with mainstream lenses. The company also specializes in providing a wide range of specialty lenses, making it a go-to destination for individuals with unique eye care requirements. These specialty lenses cater to conditions such as astigmatism, presbyopia, and various other vision impairments. Cooper's commitment to addressing the diverse needs of its customers shines through in its comprehensive selection of specialty lenses. On the other hand, the CooperSurgical segment focuses on reproductive care, fertility, and women's health. Founded in 1990, this division has rapidly become a leading provider of medical equipment related to these important areas. With a wide product range that covers all aspects of the in-vitro fertilization (IVF) cycle, CooperSurgical plays a crucial role in assisting individuals who are trying to start a family. From diagnostic equipment to devices used in assisted reproductive technology, CooperSurgical leaves no stone unturned in ensuring the best possible outcomes for patients. One of CooperSurgical's standout achievements is the development of Paragard, the only hormone-free intrauterine device (IUD) available in the United States. This cutting-edge contraceptive solution offers women an alternative to hormone-based birth control methods. With its unique copper-based design, Paragard provides a highly effective, long-term, non-hormonal option for those seeking contraception. As a result, CooperSurgical has secured a significant market share, controlling approximately 17% of the U.S. IUD market. The Cooper Companies' commitment to innovative eye care and reproductive health solutions has made it a dominant player in both markets. The company's wide-ranging products and services cater to the diverse needs of customers, ensuring they receive the highest quality care and treatment. With its strong focus on research and development, Cooper continues to evolve and introduce groundbreaking solutions that enhance the lives of its customers. Through its work, the Cooper Companies are setting new standards in eye care and reproductive health, cementing their position as industry leaders.
Website: https://www.coopercos.com
Data updated: June 2, 2026
